Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 47Breast Neoplasms 9Salivary Gland Neoplasms 2Prostate Adenocarcinoma 2Neoplasm Metastasis 2Breast Neoplasms, Male 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunctions, Psychological 1Salivary Gland Neoplasm Duct 1Primary Dysautonomias 1Patient Compliance 1PSA Level Greater Than Two 1Newly Diagnosed Oligometastatic Prostate Cancer 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia 1Kidney Diseases 1Hypertension 1Hormone Sensitive Prostate Cancer 1Hereditary Sensory and Autonomic Neuropathies 1HER2-positive Breast Cancer 1Granulosa cell tumor of the ovary 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

nilutamide 1luprolide acetate gel depot 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Salicylic Acid 1Radiation 1Protons 1Proton Therapy 1Leuprolide 1Goserelin 1Flutamide 1Docetaxel 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stage I Prostate Adenocarcinoma AJCC v7 × Leuprolide × 1 year × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡